THE ANTIEMETIC ACTIVITY OF HIGH-DOSE ALIZAPRIDE AND HIGH-DOSE METOCLOPRAMIDE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL

被引：23
|
作者：
JOSS, RA
GALEAZZI, RL
BISCHOFF, AK
PIROVINO, M
RYSSEL, HJ
BRUNNER, KW
机构：
[1] UNIV BERN,INST MED ONCOL,CH-3000 BERN,SWITZERLAND
[2] UNIV BERN,DEPT INTERNAL MED,CH-3000 BERN,SWITZERLAND
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1986年 / 39卷 / 06期
关键词：
D O I：
10.1038/clpt.1986.109
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：619 / 624
页数：6
相关论文
共 50 条
  • [1] THE ANTIEMETIC ACTIVITY OF HIGH-DOSE METOCLOPRAMIDE AND HIGH-DOSE ALIZAPRIDE IN COMBINATION WITH LORAZEPAM IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY
    MOLINO, A
    GUGLIELMO, L
    AZZOLINI, ME
    BIONDANI, P
    CAPELLI, MC
    GRANDINETTI, A
    GRISO, C
    MARTINELLI, G
    MARTINI, N
    ZANOTTI, R
    CETTO, GL
    ONCOLOGY, 1991, 48 (02) : 111 - 115
  • [2] ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE - RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY WITH HIGH-DOSE METOCLOPRAMIDE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
    IBRAHIM, EM
    ALIDRISSI, HY
    IBRAHIM, A
    ABSOOD, G
    ALDOSSARY, E
    ALJAMMAA, A
    ALETHAN, S
    ELIOPOULOS, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (03): : 283 - 288
  • [3] A RANDOMIZED DOUBLE-BLIND-STUDY OF HIGH-DOSE INTRAVENOUS PROCHLORPERAZINE VERSUS HIGH-DOSE METOCLOPRAMIDE AS ANTIEMETICS FOR CANCER-CHEMOTHERAPY
    OLVER, IN
    WOLF, M
    LAIDLAW, C
    BISHOP, JF
    COOPER, IA
    MATTHEWS, J
    SMITH, R
    BUCHANAN, L
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (11) : 1798 - 1802
  • [4] ANTIEMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE AND DEXAMETHASONE IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY - A RANDOMIZED TRIAL
    TSAVARIS, N
    TSAROUCHANOUTSOU, E
    BACOYANNIS, C
    MYLONAKIS, N
    VALILIS, P
    KOZATSANIHALIVIDI, D
    TSOUTSOS, H
    DROUFAKOU, S
    KOSMIDIS, P
    ONCOLOGY, 1992, 49 (06) : 479 - 483
  • [5] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE
    AAPRO, MS
    PLEZIA, PM
    ALBERTS, DS
    GRAHAM, V
    JONES, SE
    SURWIT, EA
    MOON, TE
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 466 - 471
  • [6] COMPARISON OF THE ANTIEMETIC EFFECT OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND HIGH-DOSE INTRAVENOUS HALOPERIDOL IN A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY
    GRUNBERG, SM
    GALA, KV
    LAMPENFELD, M
    JAMIN, D
    JOHNSON, K
    CARIFFE, P
    STRYCH, D
    KRAILO, M
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) : 782 - 787
  • [7] A RANDOMIZED, DOUBLE-BLIND COMPARISON OF THE ANTIEMETIC EFFECT OF METOCLOPRAMIDE AND LORAZEPAM WITH OR WITHOUT DEXAMETHASONE IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
    STEPHENS, SH
    SILVEY, VL
    WHEELER, RH
    CANCER, 1990, 66 (03) : 443 - 446
  • [8] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE VS ALIZAPRIDE - A RANDOMIZED CROSSOVER STUDY
    SENG, KTH
    TIONG, CE
    HIANG, TC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (03) : 282 - 284
  • [9] PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE (M) IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY
    FORD, C
    NAHATA, MC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 196 - 196
  • [10] A PROSPECTIVE RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY COMPARING THE ANTIEMETIC ACTIVITY OF ALIZAPRIDE AND METOCLOPRAMIDE IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY
    BASURTO, C
    ROILA, F
    DELFAVERO, A
    BALLATORI, E
    MINOTTI, V
    TONATO, M
    CANCER INVESTIGATION, 1988, 6 (05) : 475 - 479
12345